Gilead Snaps up Antiviral Programs From Novartis, Follows Slew of Other Pipeline-Bolstering Deals
In addition to the three preclinical assets from Novartis, Gilead has recently entered into deals to develop therapies for HIV, RA and NASH.
The Home of the Life Sciences Industry
Explore Latest News
AAIC Roundup: Alzheimer’s, Seizures, Sleep Medication, the LGBT Community and More
It was a big week for Alzheimer’s research as researchers from around the world descended on Los Angeles to attend the Alzheimer’s Association International Conference (AAIC) this week. Here's a look at some of the stories you may have missed.
- Research Roundup: The Link Between Sugary Drinks and Cancer and More
- Acacia Founder and ViiV’s Longtime CSO Are Planning to Step Down From Their Companies
- Losing the War on Antibiotic-Resistant Infections Because of Market Forces
- New Life Science Spaces and Factories Under Construction and Opening
- First U.S. SMA Patient Already Treated with Zolgensma
Get personalized job alerts
Create a job alert and receive custom job recommendations straight to your inbox.
Employers
Post jobs on BioSpace and start building your talent pipeline today. Click the button to access our easy eCommerce site, which lets you purchase and post jobs in just a few clicks.